COVID-19 resulting in bilateral pulmonary emboli and a right ventricular thrombus: association or causation? A case report.
COVID-19
Case report
Pulmonary embolism
Right ventricular thrombus
Journal
European heart journal. Case reports
ISSN: 2514-2119
Titre abrégé: Eur Heart J Case Rep
Pays: England
ID NLM: 101730741
Informations de publication
Date de publication:
Oct 2020
Oct 2020
Historique:
received:
27
04
2020
revised:
09
05
2020
accepted:
22
07
2020
entrez:
18
11
2020
pubmed:
19
11
2020
medline:
19
11
2020
Statut:
epublish
Résumé
SARS-CoV-2 is a novel viral illness originating out of Wuhan China in late 2019. This global pandemic has infected nearly 3 million people and accounted for 200 000 deaths worldwide, with those numbers still climbing. We present a 54-year-old patient who developed respiratory failure requiring endotracheal intubation from her infection with SARS-CoV-2. This patient was subsequently found to have a right ventricular thrombus and bilateral pulmonary emboli, likely contributing to her respiratory status. On the 14th day of hospitalization, the patient was successfully extubated, and 5 days later was discharged to the rehabilitation unit. SARS-CoV-2 presents primarily with pulmonary symptoms; however, many patients, particularly those who are severely ill, exhibit adverse events related to hypercoagulability. The exact mechanism explaining this hypercoagulable state has yet to be elucidated, but these thrombotic events have been linked to the increased inflammation caused by SARS-CoV-2. This novel viral illness is still largely misunderstood, but the hypercoagulable state, seen in severely ill patients, appears to play a major role in disease progression and prognosis.
Sections du résumé
BACKGROUND
BACKGROUND
SARS-CoV-2 is a novel viral illness originating out of Wuhan China in late 2019. This global pandemic has infected nearly 3 million people and accounted for 200 000 deaths worldwide, with those numbers still climbing.
CASE SUMMARY
METHODS
We present a 54-year-old patient who developed respiratory failure requiring endotracheal intubation from her infection with SARS-CoV-2. This patient was subsequently found to have a right ventricular thrombus and bilateral pulmonary emboli, likely contributing to her respiratory status. On the 14th day of hospitalization, the patient was successfully extubated, and 5 days later was discharged to the rehabilitation unit.
DISCUSSION
CONCLUSIONS
SARS-CoV-2 presents primarily with pulmonary symptoms; however, many patients, particularly those who are severely ill, exhibit adverse events related to hypercoagulability. The exact mechanism explaining this hypercoagulable state has yet to be elucidated, but these thrombotic events have been linked to the increased inflammation caused by SARS-CoV-2. This novel viral illness is still largely misunderstood, but the hypercoagulable state, seen in severely ill patients, appears to play a major role in disease progression and prognosis.
Identifiants
pubmed: 33204989
doi: 10.1093/ehjcr/ytaa276
pii: ytaa276
pmc: PMC7649511
doi:
Types de publication
Case Reports
Langues
eng
Pagination
1-5Informations de copyright
© The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology.
Références
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
J Thromb Haemost. 2020 Jun;18(6):1421-1424
pubmed: 32271988
Clin Infect Dis. 2020 Jul 28;71(15):762-768
pubmed: 32161940
J Thromb Haemost. 2020 Apr;18(4):844-847
pubmed: 32073213
J Infect Dis. 2016 Mar 1;213(5):712-22
pubmed: 26486634
J Thromb Haemost. 2020 May;18(5):1094-1099
pubmed: 32220112
Eur Heart J Case Rep. 2020 Jun 17;4(FI1):1-4
pubmed: 33089047
Clin Chem Lab Med. 2020 Jun 25;58(7):1116-1120
pubmed: 32172226
Lancet Respir Med. 2020 May;8(5):475-481
pubmed: 32105632